The main aim of this study was to investigate, using immunohistochemistry, the expression profiles of p53 and MDM2 in a Ghana breast cancer cohort and correlate findings with clinicopathological features as well as the molecular subtypes. The gene discussed is TP53; the disease is breast carcinoma.